載入...
Renal function dynamics following co‐administration of sacubitril/valsartan and empagliflozin in patients with heart failure and type 2 diabetes
AIMS: The aim of this study was to evaluate the safety profile in terms of changes in renal function after co‐treatment with sacubitril/valsartan and empagliflozin in patients with type 2 diabetes (T2D) and heart failure with reduced ejection fraction (HFrEF). METHODS AND RESULTS: This multicentre o...
Na minha lista:
| 發表在: | ESC Heart Fail |
|---|---|
| Main Authors: | , , , , , , , , , , , , , |
| 格式: | Artigo |
| 語言: | Inglês |
| 出版: |
John Wiley and Sons Inc.
2020
|
| 主題: | |
| 在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7754982/ https://ncbi.nlm.nih.gov/pubmed/32964683 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ehf2.12965 |
| 標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|